709. The Q Study - Q&A with Dr. Benjamin Greenberg

TMA Ask the Expert podcast: Q&A on Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis

Dr. Benjamin Greenberg answers questions about the currently enrolling Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis. Dr. Greenberg talks about the process of selecting participants, what qualifications must be met, and the timeline of the study. He also answers questions on the risks of participation. Dr. Greenberg explains what participation in the study entails, and what outcomes his team will look at to deem the trial successful. Questions about a possible Phase II of the trial are discussed.

ABOUT OUR GUEST SPEAKER

Dr. Benjamin Greenberg received his Bachelor of Arts degree from Johns Hopkins University and his Masters Degree in Molecular Microbiology and Immunology from the Johns Hopkins School of Public Health in Baltimore, Maryland. He completed his residency in neurology at The Johns Hopkins Hospital and then joined the faculty within the division of neuroimmunology. In January of 2009 he was recruited to the faculty at the University of Texas Southwestern Medical Center where he was named Deputy Director of the Multiple Sclerosis Program and Director of the new Transverse Myelitis and Neuromyelitis Optica Program. Dr. Greenberg is recognized internationally as an expert in rare autoimmune disorders of the central nervous system. His research interests are in both the diagnosis and treatment of transverse myelitis, neuromyelitis optica, encephalitis, multiples sclerosis and infections of the nervous system. He currently serves as the Director of the Neurosciences Clinical Research Center and is a Cain Denius Foundation Scholar.